Goals for Epilepsy Clinic Visits Trial

This study is looking at whether a tool called the "Epilepsy Visit Planner" can help improve how patients with drug-resistant epilepsy communicate with their doctors and improve their quality of life. The Epilepsy Visit Planner is a tablet-based tool that you would use in the waiting room before your clinic appointment. Researchers want to see if using this planner leads to better conversations with your healthcare provider and better overall well-being compared to not using it. They will measure this by asking you to complete questionnaires after your clinic visit and again three months later. The study is currently unclear on its status and plans to enroll 152 adult participants who have drug-resistant epilepsy and receive care at the University of Michigan Epilepsy clinics.

Study design
This is an interventional study planning to enroll 152 participants. It compares outcomes for those who use the Epilepsy Visit Planner to those who do not.
What's involved
You would complete questionnaires electronically or by phone within three days after your initial clinic visit and again at three months. If in the intervention group, you would also meet with research staff before your clinic visit to learn about the Epilepsy Visit Planner.
Compensation
Not stated in the trial record.
Follow-up
You would be followed for three months after your initial clinic visit.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05928598

Goals for Epilepsy Clinic Visits Trial

Recruiting
NAAges 18+InterventionalHealth services
University of Michigan
~152 participants
Updated 2025-10-20 on ClinicalTrials.gov
What's tested:Survey questionnairesEpilepsy Visit PlannerQuestionnaires for Providers

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Perceived Efficacy in Patient-Physician Interactions Questionnaire (PEPPI), difference in mean score between trial arms
Measured over Baseline
Drug Resistant Epilepsy
1 sites across 1 states
Michigan1
  • Chloe Hill, MD · PRINCIPAL_INVESTIGATOR · University of Michigan

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adults with drug-resistant epilepsy
Participants receiving care through the Epilepsy clinics at the University of Michigan
University of Michigan epilepsy providers

Exclusion

\<18 years old
Non-English speaking
Do not clearly have drug-resistant epilepsy
Moderate-to-severe cognitive impairment that precludes study questionnaire completion
Not University of Michigan epilepsy providers
  • Perceived Efficacy in Patient-Physician Interactions Questionnaire (PEPPI), difference in mean score between trial armsBaseline

    This is a 10-item measure with Likert scale (range 1-5 for each response) with a score range of 10-50 (higher score indicating higher perceived efficacy in communicating with providers).